Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.0K
Overview
51.0K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

788
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
788
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

673
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
673
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

739
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
739
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

506
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
506

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Lyme disease in Poland in 2023.

Przeglad epidemiologiczny·2026
Same authorSame journal

Pertussis in Poland in 2023.

Przeglad epidemiologiczny·2026
Same author

Public spending on immunisation in Poland.

Frontiers in public health·2025
Same author

Chickenpox in Poland in 2023.

Przeglad epidemiologiczny·2025
Same author

Mumps in Poland in 2023.

Przeglad epidemiologiczny·2025
Same author

Measles in Poland: 2022-2023.

Przeglad epidemiologiczny·2025

Related Experiment Video

Updated: Jan 3, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.1K

Pertussis in Poland in 2017

Agnieszka Rumik1, Iwona Paradowska-Stankiewicz1, Jolanta Rudowska1

  • 1National Institute of Public Health – National Institute of Hygiene, Department of Epidemiology of Infectious Diseases and Surveillance

Przeglad Epidemiologiczny
|November 27, 2019
PubMed
Summary

Pertussis (whooping cough) cases in Poland decreased significantly in 2017, but the bacteria still circulate. Vaccination remains the most effective strategy to prevent pertussis infection in children and infants.

Keywords:
pertussisinfectious diseasesepidemiologyPoland2017

More Related Videos

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.9K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K

Related Experiment Videos

Last Updated: Jan 3, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.1K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.9K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Compulsory pertussis vaccination in Poland since 1960 led to a sharp decline in disease incidence.
  • Recent years have shown an increase in reported pertussis cases, with incidence rates of 12.9 and 17.8 per 100,000 in 2015 and 2016, respectively.
  • Older individuals who are not fully immunized can be a source of infection for vulnerable newborns and infants.

Purpose of the Study:

  • To assess the 2017 epidemiological situation of pertussis in Poland.
  • To compare the 2017 pertussis incidence with previous years.
  • To evaluate the vaccination status of children against pertussis.

Main Methods:

  • Analysis of individual suspected pertussis case reports submitted to NIZP-PZH.
  • Utilized data from the bulletins 'Infectious diseases and poisoning in Poland in 2017' and 'Protective vaccinations in Poland in 2017'.

Main Results:

  • In 2017, 3,061 pertussis cases were recorded, with an incidence of 8.0 per 100,000 population, a 55% decrease from the previous year.
  • The highest incidence was observed in the 0-4 years age group (37.0 per 100,000), followed by 5-9 years (21.4) and 10-14 years (25.7).
  • 25% (762) of pertussis patients were hospitalized; no deaths were reported in 2017.

Conclusions:

  • The 2017 pertussis case numbers indicate ongoing bacterial circulation and population susceptibility.
  • Continued vaccination according to current schedules and expert recommendations is crucial for reducing pertussis incidence.
  • Research is ongoing in Poland to optimize pertussis vaccination schedules using both whole-cell and acellular vaccines.